{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ADH",
      "entity_text" : "ADH",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02043",
      "entity_text" : "CBZ",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "With regard to the mechanism of development of hyponatremia during therapy with CBZ, it has been reported that CBZ stimulates antidiuretic hormone (ADH) secretion and that the excess ADH binds to ADH receptors of the renal collecting tubules, resulting in cyclic adenosine monophosphate (AMP) production and excessive enhancement of the water permeability of the collecting tubules.",
  "reading_complete" : "2020-08-03T11:32:08Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:31:33Z",
  "trigger" : "stimulates",
  "evidence" : [ "CBZ stimulates antidiuretic hormone (ADH" ],
  "pmc_id" : "7364071",
  "score" : 0
}